Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eribulin + Capecitabine in Advanced Breast Cancer
NCT01323530Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jan 2010
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of eribulin in breast cancer, solid tumor, sponsored by Eisai Co., Ltd.. Started Jan 2010; status: completed.
02
Drugs
eribulin
03
Conditions
breast cancersolid tumor
Beyond the preview
Go deeper on NCT01323530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01323530.